Daniel Sirkis (@dwsir) header
Daniel Sirkis (@dwsir) profile picture

Staff scientist @UCSF. Formerly @UCBerkeley, @HHMINEWS.

San Francisco
Joined May 2011
Photo by Daniel Sirkis (@dwsir)Photo by Daniel Sirkis (@dwsir)Photo by Daniel Sirkis (@dwsir)Photo by Daniel Sirkis (@dwsir)Photo by Daniel Sirkis (@dwsir)
Daniel Sirkis retweeted
Five years ago we sketched out the designs for our first epigenome editors. Proud to see those sketches move into the clinic. You can read more about the technology underpinning our epi-editors in this preprint we recently presented at ASGCT: biorxiv.org/content/10.64898…
Announcing our first clinical trial. Scribe has secured regulatory clearance from Australia’s @TGAgovau to initiate a first-in-human clinical study of STX-1150 for the treatment of hypercholesterolemia, a major driver of atherosclerotic cardiovascular disease (ASCVD). Details🧵
3
3
558
Transforming traditional views laid by “CNS immune privilege,” our research uncovers the brain’s purposeful presentation of self – that is the brain engages with the immune system through “guardian” peptides to ensure immune tolerance. @jonykipnis nature.com/articles/s41586-0…
19
71
7
261
72,913
New paper out📢! Toxic effects of IFN-I in humans has been suggested in patients with rare monogenic autoinflammatory diseases (SAVI, CANDLE, AGS) where IFN-I are elevated. In the absence of specific inhibitors, their causal role has been difficult to prove. We now report benefit of specific anti-IFNAR1 (#Anifrolumab) in 5 patients verifying the causal role of IFN-I in these diseases: rdcu.be/dXWPw
5
67
5
229
24,896
For the first time in 114 years, biologists from the Oregon Department of Fish and Wildlife have observed a fall-run Chinook salmon returning to spawn in the Klamath Basin in Oregon, after dam removal.
418
4,732
559
41,460
1,582,289
Continuing with #crossreactivity and #TCR Another paper that I #love We simply #cant #afford to have "#holes" in the #repertoire. Virus-Specific CD4 Memory-Phenotype T Cells Are Abundant in Unexposed... sciencedirect.com/science/ar…
2
13
1
68
7,664
Daniel Sirkis retweeted
HHMI Investigator Zhijian "James" Chen of @UTSWMedCenter has been named the 2024 Albert Lasker Basic Medical Research Award winner for his discovery of the DNA-sensing cGAS enzyme, which triggers immune & inflammatory responses. 👏 👉 hhmi.news/47wJnn2
2
34
5
222
22,079
Immortal quote from the amazing geneticist Gerry Fink… “Just because it’s in Nature… … doesn’t necessarily mean it’s wrong!”
Controversial opinion: while it’s popular to say we don’t need the glam journals, scientists aspire for recognition, like an actor aspires for an Oscar and a musician aspires for a Grammy. If Nature/Science/Cell is taken away, we would need some other way to recognise good work.
4
13
226
32,276
We report many proteins not predicted by the genetic code. They are stable & abundant O( 10³ ) copies / cell. Generative mechanisms include codon-anticodon mismatches & RNA modifications. Their abundance depends on codon frequency & protein stability. biorxiv.org/content/10.1101/…
16
283
67
1,161
525,844
Daniel Sirkis retweeted
🚀 Excited for @YokoyamaLabUCSF to serve as Editor-in-Chief for @Nature_NPJ! #DementiaResearch #OpenAccess #cwowleads
I am thrilled to announce the launch of npj Dementia, for which I will be serving as the Editor-in-Chief. npj Dementia will be fully-open access and publish research that advances the field towards effective disease interventions. (1/3)
1
2
5
403
I am thrilled to announce the launch of npj Dementia, for which I will be serving as the Editor-in-Chief. npj Dementia will be fully-open access and publish research that advances the field towards effective disease interventions. (1/3)
Announcing npj Dementia, an exciting new Nature Portfolio journal, led by EIC Dr Jen Yokoyama. nature.com/npjdementia/
8
24
4
139
12,911
Daniel Sirkis retweeted
Announcing npj Dementia, an exciting new Nature Portfolio journal, led by EIC Dr Jen Yokoyama. nature.com/npjdementia/
3
11
3
53
18,340
Daniel Sirkis retweeted
When the lab veteran agrees to teach you how to run a western blot
4
19
2
339
33,261
Check out the data that goes along with our new manuscript & conduct an exciting secondary analysis of your own! @RCFNeuro @alzdemjournals
New data from the @YokoyamaLabUCSF and @UCSFmac is now available on AD Workbench. Researchers can use this dataset to identify novel disease associations, cell-specific impacts, and therapeutic targets for Alzheimer’s. Access data via AD Workbench: bit.ly/45C3zmA
7
1
23
4,062
New data from the @YokoyamaLabUCSF and @UCSFmac is now available on AD Workbench. Researchers can use this dataset to identify novel disease associations, cell-specific impacts, and therapeutic targets for Alzheimer’s. Access data via AD Workbench: bit.ly/45C3zmA
1
7
1
13
4,151